Non-Coding RNAs: Emerging Roles in the Characterization of Immune Microenvironment and Immunotherapy of Prostate Cancer

Immunotherapy, especially immune checkpoint inhibitors (ICIs), has made great progress in the treatment of various solid tumors, including prostate cancer. However, the ICIs have only shown modest outcomes in mCRPC compared with other tumors.